Berberine and Lung Cancer: From Pure Form to Its Nanoformulations

Area of Science:

• Oncology
• Pharmacology
• Nanotechnology

Background:

• Lung cancer remains a leading cause of cancer mortality globally.
• Berberine, a natural compound, exhibits anticancer properties by influencing apoptosis, autophagy, and cell cycle.
• Clinical application of berberine is limited by poor bioavailability and solubility.

Purpose of the Study:

• To review the molecular pathways targeted by berberine in lung cancer.
• To assess the efficacy of berberine in combination therapies for lung cancer.
• To explore the role of nanotechnology in improving berberine delivery for lung cancer treatment.

Main Methods:

• Literature review of studies on berberine's effects on lung cancer.
• Analysis of cellular and molecular mechanisms of berberine.
• Evaluation of combination therapies and nanodelivery systems for berberine.

Main Results:

• Berberine impacts critical cancer pathways including apoptosis, autophagy, and cell cycle arrest.
• Combination therapies involving berberine demonstrate enhanced efficacy in lung cancer models.
• Nanotechnology offers potential solutions for berberine's bioavailability and delivery challenges.

Conclusions:

• Berberine possesses significant anticancer potential for lung cancer through various molecular targets.
• Combining berberine with other treatments and utilizing nanodelivery systems could improve clinical outcomes.
• Further research into nanocarrier-based berberine formulations is warranted for lung cancer therapy.